2w5u
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | {{Seed}} | |
+ | [[Image:2w5u.jpg|left|200px]] | ||
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_2w5u", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_2w5u| PDB=2w5u | SCENE= }} | ||
- | + | ===FLAVODOXIN FROM HELICOBACTER PYLORI IN COMPLEX WITH THE C3 INHIBITOR=== | |
- | Description: Flavodoxin from Helicobacter pylori in complex with the C3 inhibitor | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ==About this Structure== |
+ | 2W5U is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Helicobacter_pylori Helicobacter pylori]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2W5U OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:19725577</ref><ref group="xtra">PMID:17623845</ref><ref group="xtra">PMID:15752617</ref><references group="xtra"/> | ||
+ | [[Category: Helicobacter pylori]] | ||
+ | [[Category: Cremades, N.]] | ||
+ | [[Category: Hermoso, J A.]] | ||
+ | [[Category: Martinez-Julvez, M.]] | ||
+ | [[Category: Perez-Dorado, I.]] | ||
+ | [[Category: Sancho, J.]] | ||
+ | [[Category: Drug discovery]] | ||
+ | [[Category: Electron transport]] | ||
+ | [[Category: Flavodoxin]] | ||
+ | [[Category: Flavoprotein]] | ||
+ | [[Category: Fmn]] | ||
+ | [[Category: Protein hinhibitor]] | ||
+ | [[Category: Transport]] | ||
+ | |||
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 23 09:51:10 2009'' |
Revision as of 07:51, 23 December 2009
FLAVODOXIN FROM HELICOBACTER PYLORI IN COMPLEX WITH THE C3 INHIBITOR
About this Structure
2W5U is a 2 chains structure of sequences from Helicobacter pylori. Full crystallographic information is available from OCA.
Reference
- Cremades N, Velazquez-Campoy A, Martinez-Julvez M, Neira JL, Perez-Dorado I, Hermoso J, Jimenez P, Lanas A, Hoffman PS, Sancho J. Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection. ACS Chem Biol. 2009 Nov 20;4(11):928-38. PMID:19725577 doi:10.1021/cb900166q
- Martinez-Julvez M, Cremades N, Bueno M, Perez-Dorado I, Maya C, Cuesta-Lopez S, Prada D, Falo F, Hermoso JA, Sancho J. Common conformational changes in flavodoxins induced by FMN and anion binding: the structure of Helicobacter pylori apoflavodoxin. Proteins. 2007 Nov 15;69(3):581-94. PMID:17623845 doi:10.1002/prot.21410
- Cremades N, Bueno M, Toja M, Sancho J. Towards a new therapeutic target: Helicobacter pylori flavodoxin. Biophys Chem. 2005 Apr 1;115(2-3):267-76. Epub 2005 Jan 7. PMID:15752617 doi:10.1016/j.bpc.2004.12.045
Page seeded by OCA on Wed Dec 23 09:51:10 2009